← Best Covered Calls
/ REGN
REGN Covered Call Analysis: Proceed With Caution Weak · 35/100
Regeneron Pharmaceuticals Inc (Healthcare) · $755.51 ·
Analysis generated Apr 15, 2026 ·
Data as of market close Apr 15
This strategy is NOT recommended for REGN right now
Score 35/100. The technical signals do not support selling covered calls on REGN at this time.
IV -44% vs avg — premiums below average, less income. MACD bearish — stock may keep falling (risk). TTM Squeeze ON — breakout imminent, risky for capped strategies.
Check back when conditions improve, or consider a different strategy.
Quick Take
REGN is trading at $755.51 with RSI at 47 (neutral territory). Options IV is at 39% — 44% below its 30-day average of 69%. Neither RSI nor IV strongly favor selling calls right now. Consider waiting for better conditions or using a different strategy.
Technical Signals
RSI (14)
47
IV Today
38.7%
IV vs 30d Avg
-44%
MACD
bearish
ADX
14
MFI
36
The Setup
REGN Covered Call
LONG STOCK
100 shares @ $755.51
SHORT CALL
$820 Jun '26 · $22.3/sh
Net Cost
$73,321
Max Profit
+$8,679
Break-even
$733.21
Projected P&L at Target
+$8,679
(11.8%)
P&L at Expiry
P&L Scenarios
What happens at different REGN prices by expiry:
| REGN Price | Today | May 6 | May 28 | Jun 19 (exp) |
|---|---|---|---|---|
| $604 (-20%) | -$13,042 | -$12,924 | -$12,881 | -$12,880 |
| $642 (-15%) | -$9,503 | -$9,255 | -$9,116 | -$9,103 |
| $680 (-10%) | -$6,179 | -$5,742 | -$5,398 | -$5,325 |
| $718 (-5%) | -$3,161 | -$2,504 | -$1,838 | -$1,548 |
| $740 (-2%) | -$1,528 | -$744 | +$144 | +$719 |
| $756 (0%) ← now | -$522 | +$338 | +$1,370 | +$2,230 |
| $771 (+2%) | +$415 | +$1,341 | +$2,504 | +$3,741 |
| $793 (+5%) | +$1,691 | +$2,693 | +$4,005 | +$6,008 |
| $820 (+9%) ← target | +$2,994 | +$4,043 | +$5,443 | +$8,679 |
| $831 (+10%) | +$3,471 | +$4,527 | +$5,931 | +$8,679 |
| $869 (+15%) | +$4,847 | +$5,870 | +$7,169 | +$8,679 |
| $907 (+20%) | +$5,868 | +$6,795 | +$7,867 | +$8,679 |
Why This Strategy, Why Now
- RSI at 47
- IV -44% vs avg — premiums below average, less income
- MACD bearish — stock may keep falling (risk)
- ADX at 14 — range-bound, perfect for selling calls
- TTM Squeeze ON — breakout imminent, risky for capped strategies
Key Risks
TTM Squeeze is ON — a volatility breakout may be imminent. If the breakout is to the upside, your short call will be tested quickly.